Sanyou Biopharmaceuticals

Sanyou Biopharmaceuticals is a global leader in high-tech biotechnology, specializing in innovative biologics R&Dand services. Sanyou integrated 4C model - "differentiated CRO, integrated CDO, innovative CPO and characteristic CRS” bridges research and manufacturing, simplifying the discovery of groundbreaking biologics worldwide.

Sanyou has nearly 300 skilled professionals in drug development and industrialization. They have a fully equipped 20,000 square meters integrated lab and three industry-leading innovative technology platforms - “super-trillion, integration, and intelligence", and can offer customizable service to support client needs. Sanyou is committed to refining their proprietary platform and introducing upgraded services and technologies. With over 1000 global collaborations, Sanyou continues to actively collaborate with pharmaceutical companies, drug R&D institutions and diagnostics companies, cultivating a collaborative growth ecosystem and a thriving community with clients and partners.
www.sanyoubio.com / crs.sanyoubio.com

The prices are on request! Contact Us by e-mail info@sobekbio.com

Human CLDN18.1 VLP PHE229

The add to cart button will appear once you select the values above

Specifications

size	20 ug/100 ug/500 ug/1 mg

Description:

Human CLDN18.1 VLP(PHE229) is expressed from HEK392.It contains AA Met 1 - Val 261 ( Accession No.:P56856-1 ).

Product type:

Protein

Host:

HEK293

Target name:

CLDN18.1

Target species:

Human

Isotype:

No tag

Buffer:

115mM Gly 4%海藻糖

Applications:

ELISA、Kinetics (BLI)、Kinetics (SPR)、Immunization

More info:

Email: info@sobekbio.com

Orders:

Email: orders@sobekbio.com